8-KThe WireRoutine
Bylaw Amendment
Filed Nov 16, 2020 · 5y ago · Accession 0001438533-20-000036
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Travere Therapeutics, Inc.
- Ticker
- TVTX
- CIK
- 1438533
- Form type
- 8-K
- Filing date
- Nov 16, 2020
- Report date
- Nov 13, 2020
- Document
- rtrx-20201113.htm
- Size
- 382 KB